In the BioHarmony Drug Report Database
Ga-68-DOTATOC, SomaKit TOC (edotreotide) is a small molecule pharmaceutical. Edotreotide was first approved as Ga-68-DOTATOC on 2016-12-08. It has been approved in Europe to treat neuroendocrine tumors and radionuclide imaging. It is known to target somatostatin receptor type 2.
Image (chem structure or protein)